Pmv Pharmaceuticals Stock Analysis

PMVP
 Stock
  

USD 17.18  1.44  9.15%   

The recent price roll up of Pmv Pharmaceuticals may encourage insiders to take a closer look at the company as it is trading at a share price of 17.18 on 644,534 in trading volume. The company management teams may have good odds in positioning the company resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.09. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Pmv Pharmaceuticals partners.
Please check Your Equity Center.
  
The Pmv Pharmaceuticals stock analysis report makes it easy to digest most publicly released information about Pmv Pharmaceuticals and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Pmv Pharmaceuticals Stock analysis module also helps to analyze the Pmv Pharmaceuticals price relationship with some important fundamental indicators such as market cap and management efficiency.

Pmv Pharmaceuticals Stock Analysis Notes

About 133.0% of the company shares are owned by institutional investors. The book value of Pmv Pharmaceuticals was at this time reported as 7.16. The company recorded a loss per share of 1.11. Pmv Pharmaceuticals had not issued any dividends in recent years. PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey. Pmv Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people. To find out more about Pmv Pharmaceuticals contact the company at 609 642 6670 or learn more at https://www.pmvpharma.com.

Pmv Pharmaceuticals Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pmv Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pmv Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Pmv Pharmaceuticals is way too risky over 90 days horizon
Pmv Pharmaceuticals appears to be risky and price may revert if volatility continues
Net Loss for the year was (64.68 M).
Pmv Pharmaceuticals currently holds about 282.99 M in cash with (51.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.21.
Latest headline from finance.yahoo.com: PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights - Yahoo Finance

Pmv Pharmaceuticals Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Pmv Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pmv Pharmaceuticals backward and forwards among themselves. Pmv Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Pmv Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Interwest Venture Management CoCommon Shares1.6 M23 M
Nextech Invest AgCommon Shares1.4 M19.7 M
Oup Management Co LlcCommon Shares989.2 K14.1 M
Assenagon Asset Management SaCommon Shares629.5 KM
Personal Cfo Solutions LlcCommon Shares550.3 K7.8 M
Evoke Wealth LlcCommon Shares133.1 K1.9 M
Sg Americas Securities LlcCommon Shares64.8 K924 K
Simplex Trading LlcCall Options9.9 K141 K
Simplex Trading LlcPut Options1.4 K19 K
Note, although Pmv Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pmv Pharmaceuticals Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 714.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pmv Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Pmv Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (12.18) % which means that it has lost $12.18 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (20.21) %, meaning that it created substantial loss on money invested by shareholders. Pmv Pharmaceuticals management efficiency ratios could be used to measure how well pmv pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 10th of August, Pmv Pharmaceuticals holds the Coefficient Of Variation of 2230.12, risk adjusted performance of 0.0645, and Semi Deviation of 7.95. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pmv Pharmaceuticals, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Pmv Pharmaceuticals, which can be compared to its competitors. Please check Pmv Pharmaceuticals jensen alpha and semi variance to decide if Pmv Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 17.18 per share. Given that Pmv Pharmaceuticals has jensen alpha of 0.3415, we recommend you to check out Pmv Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.

Pmv Pharmaceuticals Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Simple Moving Average indicator is calculated by adding the closing price of Pmv Pharmaceuticals for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Pmv Pharmaceuticals short-term fluctuations and highlight longer-term trends or cycles.
.

Pmv Pharmaceuticals Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pmv Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pmv Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pmv Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Flowers Kirsten over two months ago via Macroaxis 
Acquisition by Flowers Kirsten of 19500 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Heyman Richard A over two months ago via Macroaxis 
Acquisition by Heyman Richard A of 19500 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Orbimed Advisors Llc over two months ago via Macroaxis 
Pmv Pharmaceuticals exotic insider transaction detected
Alland Leila over two months ago via Macroaxis 
Exercise or conversion by Alland Leila of 4000 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Mack David Henry over three months ago via Macroaxis 
Exercise or conversion by Mack David Henry of 33000 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Kung Winston over three months ago via Macroaxis 
Pmv Pharmaceuticals exotic insider transaction detected
Orbimed Advisors Llc over three months ago via Macroaxis 
Pmv Pharmaceuticals exotic insider transaction detected
Mack David Henry over three months ago via Macroaxis 
Exercise or conversion by Mack David Henry of 20000 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Alland Leila over three months ago via Macroaxis 
Acquisition by Alland Leila of 104400 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Kung Winston over six months ago via Macroaxis 
Bona fide gift to Kung Winston of 2725 shares of Pmv Pharmaceuticals subject to Section 16
Flowers Kirsten over six months ago via Macroaxis 
Exercise or conversion by Flowers Kirsten of 32677 shares of Pmv Pharmaceuticals subject to Rule 16b-3
Mack David Henry over six months ago via Macroaxis 
Exercise or conversion by Mack David Henry of 9000 shares of Pmv Pharmaceuticals subject to Rule 16b-3

Pmv Pharmaceuticals Predictive Daily Indicators

Pmv Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pmv Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pmv Pharmaceuticals Forecast Models

Pmv Pharmaceuticals time-series forecasting models is one of many Pmv Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pmv Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Pmv Pharmaceuticals Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pmv Pharmaceuticals stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pmv Pharmaceuticals shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Pmv Pharmaceuticals. By using and applying Pmv Pharmaceuticals Stock analysis, traders can create a robust methodology for identifying Pmv Pharmaceuticals entry and exit points for their positions.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey. Pmv Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pmv Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module
Please check Your Equity Center. Note that the Pmv Pharmaceuticals information on this page should be used as a complementary analysis to other Pmv Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Pmv Pharmaceuticals Stock analysis

When running Pmv Pharmaceuticals price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Is Pmv Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv Pharmaceuticals. If investors know Pmv Pharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
671.3 M
Return On Assets
-0.12
Return On Equity
-0.2
The market value of Pmv Pharmaceuticals is measured differently than its book value, which is the value of Pmv Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pmv Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pmv Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Pmv Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.